Creatine treatment in muscle disorders: a meta-analysis of randomised controlled trials.
Kley
R A
RA
Department of Neurology, Neuromuscular Centre Ruhrgebiet, Kliniken Bergmannsheil, Ruhr-University Bochum, Buerkle-de-la-Camp-Platz 1, 44789 Bochum, Germany. rudolf.kley@rub.de
Tarnopolsky
M A
MA
Vorgerd
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D003401:Creatine / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D004734:Energy Metabolism / Q000187:drug effects; D005260:Female; D006012:Glycogen Storage Disease Type V / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D018737:Hand Strength; D006801:Humans; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D053580:Muscle Strength / Q000187:drug effects*; D009133:Muscular Atrophy / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D009136:Muscular Dystrophies / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D009468:Neuromuscular Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics*; D016032:Randomized Controlled Trials as Topic; D012042:Registries; D016896:Treatment Outcome
D003401:Creatine